» Articles » PMID: 34959892

Fatty Acid Metabolism and Derived-Mediators Distinctive of PPAR-α Activation in Obese Subjects Post Bariatric Surgery

Overview
Journal Nutrients
Date 2021 Dec 28
PMID 34959892
Citations 3
Authors
Affiliations
Soon will be listed here.
Abstract

Bariatric surger (BS) is characterized by lipid metabolic changes as a response to the massive release of non-esterified fatty acids (NEFA) from adipose depots. The study aimed at evaluating changes in polyunsaturated fatty acids (PUFA) metabolism and biosynthesis of the lipid mediators -acylethanolamines (NAE), as indices of nuclear peroxisome proliferator-activated receptor (PPAR)-α activation. The observational study was performed on 35 subjects (27 female, 8 male) with obesity, undergoing bariatric surgery. We assessed plasma FA and NAE profiles by LC-MS/MS, clinical parameters and anthropometric measures before and 1 and 6 months after bariatric surgery. One month after bariatric surgery, as body weight and clinical parameters improved significantly, we found higher plasma levels of -oleoylethanolamine, arachidonic and a 22:6-n3/20:5-n3 ratio as evidence of PPAR-α activation. These changes corresponded to higher circulating levels of NEFA and a steep reduction of the fat mass. After 6 months 22:6-n3/20:5-n3 remained elevated and fat mass was further reduced. Our data suggest that the massive release of NEFA from adipose tissue at 1-Post, possibly by inducing PPAR-α, may enhance FA metabolism contributing to fat depot reduction and improved metabolic parameters in the early stage. However, PUFA metabolic changes favor n6 PUFA biosynthesis, requiring a nutritional strategy aimed at reducing the n6/n3 PUFA ratio.

Citing Articles

FGF21 and its underlying adipose tissue-liver axis inform cardiometabolic burden and improvement in obesity after metabolic surgery.

Patt M, Karkossa I, Krieg L, Massier L, Makki K, Tabei S EBioMedicine. 2024; 110:105458.

PMID: 39608059 PMC: 11638646. DOI: 10.1016/j.ebiom.2024.105458.


Research progress on bariatric surgery for hyperuricemia.

Song K, Kong X, Yu Z, Xiao H, Ren Y BMC Surg. 2024; 24(1):235.

PMID: 39169366 PMC: 11337558. DOI: 10.1186/s12893-024-02525-w.


Identification of a Fatty Acid for Diagnosing Non-Alcoholic Steatohepatitis in Patients with Severe Obesity Undergoing Metabolic Surgery.

Takahashi N, Sasaki A, Umemura A, Sugai T, Kakisaka K, Ishigaki Y Biomedicines. 2022; 10(11).

PMID: 36428489 PMC: 9687903. DOI: 10.3390/biomedicines10112920.

References
1.
Gordon Bell J, Mackinlay E, Dick J, Younger I, Lands B, Gilhooly T . Using a fingertip whole blood sample for rapid fatty acid measurement: method validation and correlation with erythrocyte polar lipid compositions in UK subjects. Br J Nutr. 2011; 106(9):1408-15. DOI: 10.1017/S0007114511001978. View

2.
Kalaitzidis R, Siamopoulos K . The role of obesity in kidney disease: recent findings and potential mechanisms. Int Urol Nephrol. 2011; 43(3):771-84. DOI: 10.1007/s11255-011-9974-1. View

3.
Fu J, Gaetani S, Oveisi F, Lo Verme J, Serrano A, Rodriguez de Fonseca F . Oleylethanolamide regulates feeding and body weight through activation of the nuclear receptor PPAR-alpha. Nature. 2003; 425(6953):90-3. DOI: 10.1038/nature01921. View

4.
Borel A, Coumes S, Reche F, Ruckly S, Pepin J, Tamisier R . Waist, neck circumferences, waist-to-hip ratio: Which is the best cardiometabolic risk marker in women with severe obesity? The SOON cohort. PLoS One. 2018; 13(11):e0206617. PMC: 6224066. DOI: 10.1371/journal.pone.0206617. View

5.
Tahri-Joutey M, Andreoletti P, Surapureddi S, Nasser B, Cherkaoui-Malki M, Latruffe N . Mechanisms Mediating the Regulation of Peroxisomal Fatty Acid Beta-Oxidation by PPARα. Int J Mol Sci. 2021; 22(16). PMC: 8396561. DOI: 10.3390/ijms22168969. View